3D Contrast Enhanced Acoustic Perfusion Imaging in Adult After Subarachnoid Hemorrhage

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Caen

About this trial

Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of stroke, with three major complications : early brain injury (EBI), vasospasm and delayed cerebral ischemia (DCI). Those patients are often given care in neurocritical care. Imaging is particularly useful to diagnose these complications. Brain imaging includes CT scan, MRI and arteriography which are not easily available and need an intrahospital transportation. Furthermore, intrahospital transportation of critically ill patients is associated with significant complications Here, investigators try to show that a new non-invasive bedside device, based on 3D enhanced ultrasonography, is able to detect principal arteries of anterior circulation of the brain.

Eligibility criteria

Qualifiers

Admitted in neurologic ICU of the CHU Caen, Normandy, for a subarachnoid hemorrhage of the anterior circulation.

Usable ultrasound temporal window.

18 years old and more.

Consent of the participant or the trusted person.

Disqualifiers

non-aneurysmal subarachnoid haemorrhage.

Contraindication to ultrasound contrast agent Sonovue, including allergies to a compound.

Uncontrolled systemic hypertension.

Acute respiratory distress syndrome.

Trial design

Treatments tested in this trial

  • Transcranial Enhanced Ultrasonography localizing microscopy

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Caen

Lead sponsor

European Research Council

Collaborator